Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Which Robo Advisor Is Best For Beginners compares onboarding ease, cost structures, and portfolio options to guide first-timers.
21,622 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Gold climbs to new highs while Bitcoin retreats, setting the stage for a heated five-year debate on which asset shoul...
Inflation remains a dominant force in mid 2026 as weather patterns, AI expansion, and geopolitical tensions push up t...
A focused look at OmniAb's Q4 2025 earnings and what the numbers could mean for investors. Discover the drivers, risk...
A tight group of U.S.-listed power chip stocks built around silicon carbide and GaN technologies are rallying as elec...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
Interpol links a crypto wallet tied 20-year-old to $122.5 million moved in 10 months, prompting a worldwide push agai...
Nebius’s stock surges latest after the company lands a Meta partnership valued at up to $27 billion, building on a re...
Two tech giants with divergent business lines are converging as tech dopplegangers, challenging investors to navigate...
PayPal faces a tough stretch in the public eye, yet cash flow and a disciplined capital plan hint at upside. Here’s w...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
Opal Fuels closed 2025 with growing RNG-based fueling capacity and a clearer path to profitability. This article brea...